![]() |
Name |
Lobophorin H
|
Molecular Formula | C42H60N2O10 | |
IUPAC Name* |
methyl N-[(2R,3R,4S,6R)-4-amino-6-[[(1S,3R,6S,7E,9S,11E,13S,16S,17S,18S,20S,21R,22S)-17,23-dihydroxy-4-(hydroxymethyl)-3,8,12,18,20,22-hexamethyl-25,27-dioxo-26-oxapentacyclo[22.2.1.01,6.013,22.016,21]heptacosa-4,7,11,14,23-pentaen-9-yl]oxy]-2,4-dimethyloxan-3-yl]carbamate
|
|
SMILES |
C[C@H]1C[C@@H]([C@@H]([C@@H]2[C@@H]1[C@]3([C@@H](C=C2)/C(=C/C[C@@H](/C(=C/[C@@H]4C=C([C@@H](C[C@@]45C(=O)C(=C3O)C(=O)O5)C)CO)/C)O[C@H]6C[C@]([C@H]([C@H](O6)C)NC(=O)OC)(C)N)/C)C)O)C
|
|
InChI |
InChI=1S/C42H60N2O10/c1-20-10-13-30(53-31-18-40(7,43)35(25(6)52-31)44-39(50)51-9)21(2)15-27-16-26(19-45)24(5)17-42(27)37(48)32(38(49)54-42)36(47)41(8)29(20)12-11-28-33(41)22(3)14-23(4)34(28)46/h10-12,15-16,22-25,27-31,33-35,45-47H,13-14,17-19,43H2,1-9H3,(H,44,50)/b20-10+,21-15+,36-32?/t22-,23-,24+,25+,27+,28-,29-,30-,31-,33+,34-,35-,40-,41+,42-/m0/s1
|
|
InChIKey |
CCQMSYBSXBRZRI-QPNGBOLUSA-N
|
|
Synonyms |
Lobophorin H
|
|
CAS | NA | |
PubChem CID | 102365432 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 752.9 | ALogp: | 3.5 |
HBD: | 5 | HBA: | 11 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 187.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 54 | QED Weighted: | 0.142 |
Caco-2 Permeability: | -5.589 | MDCK Permeability: | 0.00009450 |
Pgp-inhibitor: | 0.898 | Pgp-substrate: | 1 |
Human Intestinal Absorption (HIA): | 0.628 | 20% Bioavailability (F20%): | 0.032 |
30% Bioavailability (F30%): | 0.968 |
Blood-Brain-Barrier Penetration (BBB): | 0.042 | Plasma Protein Binding (PPB): | 85.74% |
Volume Distribution (VD): | 1.336 | Fu: | 6.59% |
CYP1A2-inhibitor: | 0.003 | CYP1A2-substrate: | 0.559 |
CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.71 |
CYP2C9-inhibitor: | 0.008 | CYP2C9-substrate: | 0.004 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.085 |
CYP3A4-inhibitor: | 0.944 | CYP3A4-substrate: | 0.711 |
Clearance (CL): | 11.65 | Half-life (T1/2): | 0.033 |
hERG Blockers: | 0.18 | Human Hepatotoxicity (H-HT): | 0.638 |
Drug-inuced Liver Injury (DILI): | 0.941 | AMES Toxicity: | 0.782 |
Rat Oral Acute Toxicity: | 0.706 | Maximum Recommended Daily Dose: | 0.995 |
Skin Sensitization: | 0.373 | Carcinogencity: | 0.247 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.99 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004223 | ![]() |
0.630 | D0TG7I | ![]() |
0.291 | ||
ENC003727 | ![]() |
0.630 | D09YHJ | ![]() |
0.287 | ||
ENC003639 | ![]() |
0.600 | D01UBX | ![]() |
0.276 | ||
ENC004292 | ![]() |
0.588 | D02YIZ | ![]() |
0.274 | ||
ENC003236 | ![]() |
0.582 | D0J7OG | ![]() |
0.271 | ||
ENC003877 | ![]() |
0.581 | D0Z1ZM | ![]() |
0.270 | ||
ENC003730 | ![]() |
0.531 | D0X1WJ | ![]() |
0.269 | ||
ENC003621 | ![]() |
0.524 | D0FX2Q | ![]() |
0.268 | ||
ENC004293 | ![]() |
0.508 | D0L6QI | ![]() |
0.268 | ||
ENC004294 | ![]() |
0.502 | D05CHI | ![]() |
0.264 |